Institute Of Cellular Therapies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 25-12-2024
- Paid Up Capital ₹ 1.00 M
as on 25-12-2024
- Company Age 18 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
About Institute Of Cellular Therapies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Jamal Khan and Sharmin Yaqin serve as directors at the Company.
- CIN/LLPIN
U85191DL2006PTC150248
- Company No.
150248
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jun 2006
- Date of AGM
25 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Institute Of Cellular Therapies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sharmin Yaqin  | Director | 26-Jun-2007 | Current |
| Jamal Khan | Director | 26-Jun-2006 | Current |
Financial Performance of Institute Of Cellular Therapies.
Enhance accessibility to Institute Of Cellular Therapies's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Institute Of Cellular Therapies?
In 2023, Institute Of Cellular Therapies had a promoter holding of 74.00% and a public holding of 26.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Optimum Therapeutics Private LimitedActive 13 years 1 month
Jamal Khan and Sharmin Yaqin are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Institute Of Cellular Therapies?
Unlock and access historical data on people associated with Institute Of Cellular Therapies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Institute Of Cellular Therapies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Institute Of Cellular Therapies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
